Key Highlights
- GridAI Technologies (NASDAQ:GRDX) posted a nine-month net loss of USD 19.9 million, against USD 3.4 million a year earlier, with a USD 10.1 million Goodwill Impairment as the main driver.
- Revenue reached only USD 38,110 in the third quarter and USD 162,194 over nine months, while nine-month cost of services of USD 805,187 produced a gross loss of USD 642,993.
- Cash held at USD 239,834 on September 30, 2026, against a Working Capital Deficit near USD 11.0 million and an accumulated deficit near USD 228.0 million.
- The company advanced USD 5.0 million to Pronghorn Resources through a secured convertible note and collected roughly USD 11.0 million of financing cash after quarter end.
A Goodwill Write-Down on the Grid AI Acquisition
GridAI Technologies (NASDAQ:GRDX), previously known as Entero Therapeutics, lodged its Quarterly Report on November 16, 2026. Based in Boca Raton, the company now runs an AI-driven energy optimization unit, Grid AI Corp., which it acquired on September 30, 2025, and its older gastrointestinal drug program, built on Adrulipase for exocrine pancreatic insufficiency, remains part of the operation. Because the purchase completed on the final day of the comparison period, the prior-year numbers largely describe the legacy drug operation. Inside the nine-month loss, the AI segment recorded a goodwill impairment of USD 10,070,124, leaving goodwill on the Balance Sheet at USD 14.0 million, down from USD 24.1 million at the December 31, 2025 mark.
Minimal Revenue Set Against Climbing Overhead
Revenue came in at USD 38,110 for the quarter and USD 162,194 for the nine months, with nothing reported a year earlier. Quarterly cost of services of USD 30,849 left a Gross Profit of USD 7,261, yet the nine-month figure swung to a gross loss of USD 642,993. Overheads grew: quarterly G&A went from USD 0.93 million to USD 3.64 million, and nine-month G&A from USD 2.4 million to USD 9.0 million. The quarterly net loss came in at USD 3.42 million against USD 1.15 million a year before. After non-controlling interests and preferred dividends the per-share figure was USD 0.27, and nine-month loss per share was USD 2.36.
Going Concern Wording and Cash Raised After Quarter End
Management's Going Concern conclusion rests on cash of USD 239,834, a working capital shortfall of about USD 11.0 million and an accumulated deficit of roughly USD 228.0 million. Around USD 11.0 million of financing-related receipts arrived through November 9, 2026, though the company says that does not eliminate the need for more capital. After quarter end, further funds went to Pronghorn Resources, a Natural Gas producer, taking principal under the note to USD 5.0 million, due by December 31, 2026. The company also issued more than 2.2 million shares in October, leaving 10,265,090 outstanding on November 16, 2026. A Nasdaq notice from April 2026 about a late Annual Report has, according to the filing, since been resolved.
Where Things Stand
The impairment writes down the Grid AI Acquisition by USD 10.1 million, which is about half of USD 19.9 million, the nine-month net loss, so the headline loss reflects accounting rather than a revenue collapse. GridAI Technologies (NASDAQ:GRDX) still earns very little, carries an accumulated deficit near USD 228.0 million and includes going concern language, though post-quarter receipts of USD 11.0 million eased near-term pressure. Next markers include AI segment revenue, repayment of the Pronghorn note by December 31, 2026, further share issuance and the Nasdaq compliance record.
_11_19_2026_19_55_10_829397.jpg)





Please wait processing your request...